کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
6001147 1182945 2015 7 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Comparison of dosing algorithms for acenocoumarol and phenprocoumon using clinical factors with the standard care in the Netherlands
ترجمه فارسی عنوان
مقایسه الگوریتم های دوز برای آکنووکومارول و فنپروکومون با استفاده از عوامل بالینی با مراقبت های استاندارد در هلند
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی کاردیولوژی و پزشکی قلب و عروق
چکیده انگلیسی


- The effect of using clinical dosing algorithm was compared with standard care.
- A clinical dosing algorithm for acenocoumarol improved the quality of anticoagulation.
- Clinical dosing algorithm for phenprocoumon did not improve anticoagulation control.

BackgroundIt has not been investigated how much the use of clinical factors in a dosing algorithm improves the percentage of time in therapeutic range (TTR). The present study aimed to compare the effect of dosing algorithms for acenocoumarol and phenprocoumon including clinical patient characteristics with standard care in the Netherlands.Setting: The pre-EU-PACT study, an observational study in the Netherlands, was used to obtain standard care data. Data from the Dutch patients in the EU-PACT trial (comparing the use of a clinical algorithm with and without genetic information) was used for the clinical dosing algorithm.MethodsFor both acenocoumarol and phenprocoumon, the percentage of time in, below and above therapeutic International Normalized Ratio (INR) range during 12 weeks after treatment initiation were assessed in both studies.ResultsDuring the weeks 2-12, the clinical dosing algorithm of acenocoumarol (80 patients) led to a higher TTR (74.3% versus 68.0% in range 2.0-3.5, 95% Confidence interval [CI] difference: 0.5% to 11.8%), and a reduced percentage of time below INR 2 and above INR 3.5, compared with standard care (272 patients). For phenprocoumon, compared with standard care (484 patients), 80 patients treated by the dosing algorithm did not obtained a significantly higher TTR in range 2.0-3.5 or a lower percentage of time above 3.5, however, they spent more time with INR below 2.ConclusionThe use of a clinical dosing algorithm for acenocoumarol seemed to improve the quality of anticoagulation therapy during the treatment of initial 2-12 weeks. For phenprocoumon, there was no statistically difference in anticoagulation control.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Thrombosis Research - Volume 136, Issue 1, July 2015, Pages 94-100
نویسندگان
, , , , , , ,